CD24/Siglec-10 Blocking Peptide (CSBP) contains a sequence engineered to disrupt CD24-Siglec-10 binding interfaces. Charged and aromatic residues provide targeted recognition of protein surfaces. Researchers study its binding kinetics, conformational dynamics, and specificity. Applications include receptor-ligand mapping, PPI inhibition modeling, and structural-motif exploration.
CAT No: R2842
Synonyms/Alias:CD24/Siglec-10 blocking peptide, CSBP; HY-P10091; CS-0906803
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.